2019 Transplant and Cellular Therapies Educational Symposium and Open House

Boston, MA US
September 13, 2019

This educational symposium will focus on current practices and advances in stem cell transplant and CAR-T cell therapy. The program will feature presentations and panel discussions covering the critical aspects of patient care before and after treatment. Care coordination, common and advanced toxicities and infections, and the latest practice in stem cell and novel immune effector cell therapies will be discussed.

Target Audience

This activity is intended for local referring providers, nurses, PAs, pharmacists, payer representatives, case managers

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Demonstrate comprehension of the referral process and care coordination between the community oncologist and the transplant team, including the pre-transplant workup process.
  2. Identify common and uncommon post-treatment toxicities post-treatment and differentiate between various common, chronic, and advanced infections post-treatment.
  3. Demonstrate comprehension of the use of haploidentical transplantation and its practicality.
  4. Review other non-infectious concerns that may present during short-term and long-term recovery from treatment.
  5. Categorize common toxicities during CAR T-cell treatment.
  6. Discuss latest therapies in research and clinical practice.

Additional Information

Provided by: 

Dana-Farber Cancer Institute and Partners HealthCare System

 





Course summary
Available credit: 
  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 Nursing
  • 5.75 Participation
Course opens: 
05/30/2019
Course expires: 
10/13/2019
Event starts: 
09/13/2019 - 9:00am
Event ends: 
09/13/2019 - 4:00pm
Cost:
$25.00
Jimmy Fund Auditorium
35 Binney Street
Boston, MA 02215
United States

Corey Cutler, MD, MPH – Course Director
Associate Professor of Medicine, Harvard Medical School;
Director, Stem Cell Transplant Survivorship Clinic,
Dana-Farber Cancer Institute 

Dr. Cutler received his MD from McGill University, Montreal, Canada. He subsequently received his MPH from the Harvard school of Public Health. He completed postgraduate training in Internal Medicine at Royal Victoria Hospital, Montreal, followed by a fellowship in Hematology/Oncology at DFCI. In 2002, he joined DFCI, where he currently is a member of the Hematologic Malignancies staff. His clinical interests include leukemias, lymphoma, multiple myeloma, myelodysplasia, and transplant.
 

Cindy Albert
Associate Director, Stem Cell Transplant Donor Services,
Dana-Farber Cancer Institute

Rachel Beaver, RN
Nurse Navigator, Dana-Farber Cancer Institute

Courtney Bellomo, MD
Physician, Hematologic Malignancies and Stem Cell Transplant,
New York Oncology Hematology

Stacey Chuma, RN
Nurse Navigator, Dana-Farber Cancer Institute

Sara Close, PA
Physician Assistant, Donor Program, 
Dana-Farber Cancer Institute

Jessica Driscoll, DNP, ANP-BC
Nurse Director, Division of Stem Cell Transplant and Cellular Therapies,
Dana-Farber Cancer Institute

Amy Emmert, MScPH
Vice President, Hematopoietic Stem Cell Transplant and Cellular Therapies Service Line Operations
Dana-Farber Cancer Institute

Ilene Galinsky, NP
Clinical Nurse Practitioner, Division of Leukemia,
Dana-Farber Cancer Institute

Cinda Gaumer, RN
Nurse Navigator, Dana-Farber Cancer Institute

Sarah Hammond, MD
Instructor in Medicine, Harvard Medical School

Caron Jacobson, MD
Instructor in Medicine, Harvard Medical School
Medical Director, Immune Effector Cell Therapy Program,
Dana-Farber Cancer Institute

Amy Joyce, ANP, AOCN
Clinical Transplant Nurse Practitioner,
Division of Transplant and Cellular Therapies,
Dana-Farber Cancer Institute

Rizwan Romee, MD
Faculty of Medicine, Harvard Medical School;
Director, Haploidentical Donor Transplant Program,
Dana-Farber Cancer Institute

Michelle Takahashi, RN
Nurse Navigator, Dana-Farber Cancer Institute

Nathaniel Treister, DMD, DMSc
Associate Professor of Oral Medicine, Infection and Immunity,
Harvard School of Dental Medicine;
Clinical Director, Oral Medicine and Oral Oncology,
Dana-Farber/Brigham and Women’s Cancer Center

Cathy Wu, MD
Chief, Division of Stem Cell Transplant and Cellular Therapies,
Dana-Farber Cancer Institute

Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for Physicians.

Partners HealthCare System designates this live activity for a maximum of 5.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Nursing CE:
Dana-Farber Cancer Institute is an approved provider of continuing nursing education by the American
Nurses Association Massachusetts, an accredited approver by the American Nurses’ Credentialing Center’s
Commission on Accreditation. Nurses should claim only the credit commensurate with the extent of their participation
in the activity. A maximum of 5.75 Contact Hours will be awarded upon completion of an evaluation.

Available Credit

  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 Nursing
  • 5.75 Participation

Accreditation Period

Course opens: 
05/30/2019
Course expires: 
10/13/2019

Price

Cost:
$25.00
Please login or register to take this course.

Our Course Coordinator can assist you with any special needs (i.e., physical, dietary, etc). Please contact Justin Solle prior to the live event at Justin_Solle@DFCI.HARVARD.EDU or  617-632-3069.

If you are having difficulty registering for the event, please reach out to the Partners Office of Continuing Professional Development at partnerscpd@partners.org


Full Tuition$25
Residents/Fellows at Dana Farber and BWHFree
Other Health Care Professionals$25
Scientists $25

Cancellation Policy:
Registrations cancelled on or before August 30, 2019 will be refunded, less a $15 administrative fee. Registrations cancelled after August 30, 2019 will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.